Cargando…

CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany

Detalles Bibliográficos
Autores principales: Kranz, Lena M., Birtel, Matthias, Hilscher, Lina, Grunwitz, Christian, Petschenka, Jutta, Vascotto, Fulvia, Vormehr, Mathias, Voss, Ralf-Holger, Kreiter, Sebastian, Diken, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137546/
https://www.ncbi.nlm.nih.gov/pubmed/27435168
http://dx.doi.org/10.1080/21645515.2016.1206677
_version_ 1782471938685272064
author Kranz, Lena M.
Birtel, Matthias
Hilscher, Lina
Grunwitz, Christian
Petschenka, Jutta
Vascotto, Fulvia
Vormehr, Mathias
Voss, Ralf-Holger
Kreiter, Sebastian
Diken, Mustafa
author_facet Kranz, Lena M.
Birtel, Matthias
Hilscher, Lina
Grunwitz, Christian
Petschenka, Jutta
Vascotto, Fulvia
Vormehr, Mathias
Voss, Ralf-Holger
Kreiter, Sebastian
Diken, Mustafa
author_sort Kranz, Lena M.
collection PubMed
description
format Online
Article
Text
id pubmed-5137546
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-51375462016-12-11 CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany Kranz, Lena M. Birtel, Matthias Hilscher, Lina Grunwitz, Christian Petschenka, Jutta Vascotto, Fulvia Vormehr, Mathias Voss, Ralf-Holger Kreiter, Sebastian Diken, Mustafa Hum Vaccin Immunother Meeting Report Taylor & Francis 2016-07-19 /pmc/articles/PMC5137546/ /pubmed/27435168 http://dx.doi.org/10.1080/21645515.2016.1206677 Text en © 2016 The Author(s). Published with license by Taylor & Francis. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Meeting Report
Kranz, Lena M.
Birtel, Matthias
Hilscher, Lina
Grunwitz, Christian
Petschenka, Jutta
Vascotto, Fulvia
Vormehr, Mathias
Voss, Ralf-Holger
Kreiter, Sebastian
Diken, Mustafa
CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
title CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
title_full CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
title_fullStr CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
title_full_unstemmed CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
title_short CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
title_sort cimt 2016: mechanisms of efficacy in cancer immunotherapy — report on the 14th annual meeting of the association for cancer immunotherapy may 10–12 2016, mainz, germany
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137546/
https://www.ncbi.nlm.nih.gov/pubmed/27435168
http://dx.doi.org/10.1080/21645515.2016.1206677
work_keys_str_mv AT kranzlenam cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany
AT birtelmatthias cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany
AT hilscherlina cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany
AT grunwitzchristian cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany
AT petschenkajutta cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany
AT vascottofulvia cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany
AT vormehrmathias cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany
AT vossralfholger cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany
AT kreitersebastian cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany
AT dikenmustafa cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany